Charles Cherington - 02 Dec 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role: Director, 10%+ Owner
Signature: /s/ Sandra Gurrola, Power of Attorney for Charles Cherington
Issuer symbol: ERNA
Transactions as of: 02 Dec 2022
Net transactions value: +$923,999
Form type: 4
Filing time: 06 Dec 2022, 20:02:08 UTC
Previous filing: 24 Oct 2022
Next filing: 06 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERNA	Common Stock	Purchase	$858,560	+261,756	+89%	$3.28	556,465	02 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Warrants (right to buy)	Purchase	$65,439	+523,512		$0.1250^*	523,512	02 Dec 2022	Common Stock, par value $0.005 per share	523,512	$3.28	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.

Content

The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.